Methods for reducing or eliminating the need for lipoprotein apheresis in patients with… Grant US-11904017-B2 United States of America 20 Feb 2024
Stabilized formulations containing anti-PCSK9 antibodies Grant US-11673967-B2 United States of America 13 Jun 2023
Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) Application JP-2022133396-A Japan 13 Sep 2022
Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with… Grant US-11306155-B2 United States of America 19 Apr 2022
Human antibodies to PCSK9 for use in methods of treating particular groups of subjects Grant US-11246925-B2 United States of America 15 Feb 2022
Methods for reducing lipoprotein(a) levels by administering an inhibitor of proprotein… Grant US-11116839-B2 United States of America 14 Sep 2021
Methods for inhibiting atherosclerosis by administering an anti-PCSK9 antibody Grant US-10995150-B2 United States of America 04 May 2021
Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) Application JP-2020183439-A Japan 12 Nov 2020
Methods for reducing or eliminating the need for lipoprotein apheresis in patients with… Grant US-10772956-B2 United States of America 15 Sep 2020
Stabilized formulations containing anti-PCSK9 antibodies Grant US-10752701-B2 United States of America 25 Aug 2020
METHODS FOR TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (HEFH) Application EP-3677277-A1 European Patent Office 08 Jul 2020
Methods for treating patients with heterozygous familial hypercholesterolemia (heFH) with… Grant US-10544232-B2 United States of America 28 Jan 2020
Methods for inhibiting atherosclerosis by administering an inhibitor of PCSK9 Grant US-10494442-B2 United States of America 03 Dec 2019
Stabilized formulations containing anti-PCSK9 antibodies Grant US-10472425-B2 United States of America 12 Nov 2019
Dosing regimens for use with PCSK9 inhibitors Grant US-10428157-B2 United States of America 01 Oct 2019
Methods for reducing remnant cholesterol and other lipoprotein fractions by administering… Grant US-10111953-B2 United States of America 30 Oct 2018
Methods for reducing lipoprotein(a) levels by administering an inhibitor of proprotein… Grant US-10076571-B2 United States of America 18 Sep 2018
Method for treating a patient having heterozygous familial hypercholesterolemia (heFH) Application JP-2017528427-A Japan 28 Sep 2017
Method for treating high cardiovascular risk patients with hypercholesterolemia Application JP-2017522316-A Japan 10 Aug 2017
Methods for treating hypercholesterolemia and reducing LDL-C using antibodies to PCSK9 Grant US-9724411-B2 United States of America 08 Aug 2017
Pharmaceutical compositions comprising human antibodies to PCSK9 Grant US-9682013-B2 United States of America 20 Jun 2017
ANTI-PCSK9 INHIBITORY ANTIBODIES FOR TREATING PATIENTS WITH HYPERLIPIDEMIA UNDERGOING… Application WO-2017031151-A1 World Intellectual Property Organisation (WIPO) 23 Feb 2017
Method of reducing cholesterol levels using a human anti-PCSK9 antibody Grant US-9561155-B2 United States of America 07 Feb 2017
METHODS FOR TREATING PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA (heFH) Application WO-2016011256-A1 World Intellectual Property Organisation (WIPO) 21 Jan 2016
METHODS FOR TREATING PATIENTS WITH HYPERCHOLESTEROLEMIA THAT IS NOT ADEQUATELY CONTROLLED… Application WO-2015123423-A3 World Intellectual Property Organisation (WIPO) 08 Oct 2015